Mix on talent
Beyond sales, where else are contract teams driving impact?
Beyond sales, where else are contract teams driving impact?
In this Mix on Talent clip, Mishka Symonette – a practice leader with over 20 years of experience in managing global recruitment solutions – explores a strategic shift in the life sciences ecosystem. While contract teams are traditionally associated with sales, organizations are increasingly leveraging flexible models to scale scientific communications and clinical operations with high precision.
The need for agility is paramount, particularly for emerging biotech and pharmaceutical companies navigating the complexities of Phase I clinical trials. As timelines shift and milestones accelerate, the ability to deploy specialized expertise on an interim basis (typically 12 – 18 months) allows organizations to maintain momentum without the long-term overhead of permanent headcount.
Insights
Key takeaways for your talent strategy:
Impact Across the Lifecycle
Contract talent is no longer a tool reserved solely for the commercial stage. Today, high-performing contract professionals drive value across critical functions, including Medical Affairs, Medical Writing, and Safety.
Specialized Clinical Support
As companies reach pivotal Phase I milestones, there is a rising need for specialized trial coordination, data management, and biometrics. Mix CTO provides the scientific depth required to support these foundational stages.
Strategic Agility
For many organizations, an outsourced interim model is the most relevant approach to manage compressed timelines. This delivers strategic flexibility without compromising on the quality or cultural alignment of the talent.
At Mix, we believe the best talent solutions are built on behavioral science and custom assessments that ensure the “right mix” for long-term success.